Iqvia Holdings Inc.
IQVQ1 2025(IQV Q4 FY2024)Estimated4% AI
AI Revenue %
4%
AI Fair Value
$866.8M
AI Revenue (Q)
$444.6M
Total Revenue (Q)
$11.1B
Source: SEC EDGAR 10-K Filing
View 10-K on SEC.govAnalysis
No AI revenue breakout. FY2024 TAS was $6,160M, 9M was $4,502M, so Q4 TAS = $1,658M. FY2024 total was $15,405M, 9M was $11,447M, so Q4 total = $3,958M. TAS was 41.9% of Q4 total. The 2024 10-K prominently features 'Healthcare-grade AI' and states IQVIA is 'committed to using AI responsibly.' AI penetration of TAS estimated at ~9.5% = ~$158M, or ~4.0% of total revenue. This reflects IQVIA's accelerating AI integration while acknowledging the bulk of TAS remains traditional data/analytics.
Analyzed by claude-opus-4-6
Quoted Figures
Technology & Analytics Solutions revenues $6,160M for FY2024 (implies Q4 $1,658M); Total revenues $15,405M (implies Q4 $3,958M)
10-K filed 2024-12-31, Segment Data
IQVIA s portfolio of solutions are powered by IQVIA Connected Intelligence to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI, advanced analytics, the latest technologies and extensive domain expertise.
10-K filed 2024-12-31, Item 1 Business
We are committed to using artificial intelligence ('AI') responsibly, ensuring that our AI-powered capabilities are grounded in privacy, regulatory compliance, and patient safety.
10-K filed 2024-12-31, Item 1 Business
Our scaled and growing information set contains approximately 64 petabytes of unique proprietary data
10-K filed 2024-12-31, Item 1 Business
AI Products Identified (Ring 1)
IQVIA Connected Intelligence (Healthcare-grade AI)AI-powered clinical trial optimizationAI-driven real world evidence analyticsNLP-based pharmacovigilanceAI-enhanced commercial analytics
AI-Enabled Items (Ring 2 — Not Counted)
These items use AI but are not counted in the AI revenue estimate because they primarily serve non-AI functions.
Traditional data subscriptions and information servicesLegacy analytics platformsClinical research services (non-AI CRO)Contract sales and medical solutions
Confidence Tier
EstimatedNo direct AI revenue disclosure — estimated from product mix